<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260427069187N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-11</date_registration>
      <primary_sponsor>Shahid Beheshti University</primary_sponsor>
      <public_title>Effect of cognitive rehabilitation on cognitive and behavioral performance in adolescents with ADHD</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of transferability of remediation and compensation-based cognitive rehabilitation on cognitive and behavioral performance in adolescents with attention deficit-hyperactivity disorders (ADHD)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-05-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/89690</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Participants were assigned individually and randomly to each group through a lottery. They were explained about the number of sessions, and none of them were aware of the existence of different intervention groups, Blinding description: After providing informed consent, participants were informed that they were taking part in a study investigating the effects of cognitive tasks on cognitive performance. However, they were not informed about their group allocation, the nature of the interventions, or the primary study hypothesis. Therefore, the participants were blinded to treatment allocation. After completion of all outcome assessments at the end of the study, participants received a full explanation of the study objectives, interventions, and group allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Attention deficit-hyper activity disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Program for Executive Function Training (PETRA). PETRA combines psychoeducation training with compensatory strategies to educate adolescents about the neurological deficits underlying their behavioral problems and how to manage them using specific strategies and skills. Intervention 2: Intervention group: Attentive Rehabilitation of Attention and Memory (ARAM). ARAM includes tasks for inhibition, sustained attention, working memory, and shifting attention was used for remediation training. Intervention 3: Control group: Emotional Face Recognition Program (AREF): The goal of this program is to train emotional recognition, and because it was unrelated to the goals of the study, it was considered as a placebo intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data file will be published in the form of a scientific article that will describe the results of the analysis of the subjects' data, the method of analysis, the results, and the detailed protocol of the interventions.

When:
Access period from 2026

To whom:
Psychological researchers

Conditions:
Psychologists to implement the intervention protocol on clients, can correspond and have documentation.

Where to obtain:
Applicants should contact a_sarrajkhorrami@sbu.ac.ir.

How to obtain:
Applicants should email the reason for their application and also their resume. After reviewing and if the evidence is sufficient, the document will be sent to them.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Vahid Nejati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti University, Shahid Shahriari Square, Evin, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2990 2365</telephone>
        <email>vhdnejati1@gmail.com</email>
        <affiliation>Shahid Beheshti University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Vahid Nejati</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti University, Shahid Shahriari Square, Evin, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2990 2365</telephone>
        <email>vhdnejati1@gmail.com</email>
        <affiliation>Shahid Beheshti University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The participant has been diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).
The participant must be between 10 and 18 years of age.
The participants must not have any comorbid psychiatric disorders.</inclusion_criteria>
      <agemin>10 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Participants are unwilling to participate in the study or complete the study questionnaires and assessments.
Participants are receiving any concurrent psychological intervention.
Participants have any comorbid psychiatric disorders.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F90.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Attention-deficit hyperactivity disorder, predominantly inattentive type</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Program for Executive Function Training (PETRA). PETRA combines psychoeducation training with compensatory strategies to educate adolescents about the neurological deficits underlying their behavioral problems and how to manage them using specific strategies and skills.</i_keyword>
      <i_keyword>Intervention group: Attentive Rehabilitation of Attention and Memory (ARAM). ARAM includes tasks for inhibition, sustained attention, working memory, and shifting attention was used for remediation training.</i_keyword>
      <i_keyword>Control group: Emotional Face Recognition Program (AREF): The goal of this program is to train emotional recognition, and because it was unrelated to the goals of the study, it was considered as a placebo intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Executive Functions. Timepoint: Before intervention, Immediately after intervention and one month after the intervention. Method of measurement: Wisconsin test; Two-back; Delay discounting; Tower of Hanoi; Stop-Signal; Balloon Analogue Risk Task; Circle tracing.</prim_outcome>
      <prim_outcome>Behavioral Performance. Timepoint: Before intervention, Immediately after intervention and one month after the intervention. Method of measurement: Swanson ADHD Rating Scale; Pittsburgh Sleep Quality Index; BRIEF executive function questionnaire; Child Behavior Checklist.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-07-06</approval_date>
        <contact_name>Research Ethics committees of Shahid Beheshti University</contact_name>
        <contact_address>Shahid Beheshti University, Shahid Shahriari Square, Evin, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
